Top 10 Generic Pharma companies by revenue 2014
Posted on28 Nov 2015
Tagsactavis, Aspen, Aurobindo, Cipla, DRL, Fresenius Kabi, Hospira, novartis, sandoz, Stada Arzneimittel, Teva, Top 10 Generic Pharma companies by revenue 2014
Comments0
Teva – $9.1 billion Novartis (Sandoz) – $8.5 billion Allergan – $6.6 billion Mylan – $6.5 billion Actavis – $4.5 billion Aspen... Read More
Lannett has acquired Kremers Urban Pharmaceuticals for around US$1.23 billion
Pharma manufacturer Lannett has completed its ‘transformational acquisition’ of Kremers Urban Pharmaceuticals for around US$1.23 billion. Lannett has acquired KU from global... Read More
Pfizer to acquire Allergan for 150 Billion
Acquiring Company: Pfizer Acquired Company: Allergan Deal Value: $150 billion (Approx.) Few facts about the deal 1. The deal will be the... Read More
USFDA approval of Ninlaro to treat multiple myeloma
Drug Name(s) NINLARO FDA Application No. (NDA) 208462 Active Ingredient(s) IXAZOMIB Company MILLENNIUM PHARMS Original Approval or Tentative Approval Date November 20,... Read More
LEO Pharma Buys Astellas’ Dermatology Business for $725M
Astellas Pharma will sell its global dermatology business to LEO Pharma for €675 million ($724.7 million), a year after the seller lost... Read More
Sanofi, Lexicon Pharma enter licensing deal for sotagliflozin to treat diabetes
Sanofi and Lexicon Pharmaceuticals, Inc. have entered into a collaboration and license agreement for the development and commercialization of sotagliflozin, an investigational... Read More
AstraZeneca agrees to acquire US biotech firm ZS Pharma for $2.7bn
Posted on07 Nov 2015
Comments0
AstraZeneca has agreed to buy ZS Pharma of the US for $2.7bn in a move to strengthen its product portfolio. ZS Pharma... Read More
A case of licensing mega deal : Sanofi – Hanmi Pharmaceutical for the development of investigational diabetes medicines
Posted on06 Nov 2015
TagsA case of pharma licensing mega deal, drug licensing, efpeglenatide, Globalpharma sanofi, GLP-1 Receptor Agonists, GLP1-agnostics, Hanmi Pharmaceutical, inlicensing in pharma, Sanofi, Sanofi - Hanmi Pharmaceutical for the development of investigational diabetes medicines
Comments0
South Korean pharmaceutical company Hanmi Pharmaceutical Co. said Thursday that it has reached a license agreement with global drugmaker Sanofi to develop... Read More
Court order rules in favour of Roche, prevents Reliance to launch Herceptin Biosimilar in India
The Delhi High Court has blocked Reliance Life Sciences from launching a copy of Swiss pharma company Roche’s breast cancer drug trastuzumab.... Read More
Bristol-Myers Squibb to Acquire Cardioxyl Pharma
Bristol-Myers Squibb and Cardioxyl Pharmaceuticals, Inc. announced that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all... Read More